Empagliflozin Improves Endothelial and Cardiomyocyte Function in Human Heart Failure With Preserved Ejection Fraction via Reduced Pro-Inflammatory-Oxidative Pathways and Protein Kinase Gα Oxidation
- Publication date
- 19 March 2021
- Publisher
- 'Oxford University Press (OUP)'